etidronate has been researched along with Osteoarthritis, Hip in 3 studies
Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.
Osteoarthritis, Hip: Noninflammatory degenerative disease of the hip joint which usually appears in late middle or old age. It is characterized by growth or maturational disturbances in the femoral neck and head, as well as acetabular dysplasia. A dominant symptom is pain on weight-bearing or motion.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Forty-four women who had undergone cementless total hip arthroplasty (THA) were selected for determination of the optimum dosage of etidronate in the treatment of stress shielding after surgery." | 2.71 | Efficacy of different dosing schedules of etidronate for stress shielding after cementless total hip arthroplasty. ( Fuji, T; Masuhara, K; Yamaguchi, K; Yamasaki, S, 2005) |
| "Comorbid factors such as ischemic heart disease, hip osteoarthritis, and higher values of FRAX blunted the effects of QOL of the treatment." | 1.38 | The effect of risedronate (17.5 mg/week) treatment on quality of life in Japanese women with osteoporosis: a prospective observational study. ( Hayakawa, Y; Iinuma, N; Itoh, M; Iwayama, S; Kamisaki, T; Nakamura, T; Nishikawa, M; Osawa, M; Suzuki, H; Yamaguchi, H, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vasileiadis, GI | 1 |
| Sakellariou, VI | 1 |
| Kelekis, A | 1 |
| Galanos, A | 1 |
| Soucacos, PN | 1 |
| Papagelopoulos, PJ | 1 |
| Babis, GC | 1 |
| Nakamura, T | 1 |
| Osawa, M | 1 |
| Itoh, M | 1 |
| Yamaguchi, H | 1 |
| Iinuma, N | 1 |
| Hayakawa, Y | 1 |
| Suzuki, H | 1 |
| Kamisaki, T | 1 |
| Iwayama, S | 1 |
| Nishikawa, M | 1 |
| Yamaguchi, K | 1 |
| Masuhara, K | 1 |
| Yamasaki, S | 1 |
| Fuji, T | 1 |
1 trial available for etidronate and Osteoarthritis, Hip
| Article | Year |
|---|---|
Efficacy of different dosing schedules of etidronate for stress shielding after cementless total hip arthroplasty.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Arthroplasty, Replacement, Hip; Bone Density; Coated | 2005 |
2 other studies available for etidronate and Osteoarthritis, Hip
| Article | Year |
|---|---|
Prevention of heterotopic ossification in cases of hypertrophic osteoarthritis submitted to total hip arthroplasty. Etidronate or Indomethacin?
Topics: Aged; Arthroplasty, Replacement, Hip; Etidronic Acid; Female; Humans; Indomethacin; Male; Middle Age | 2010 |
The effect of risedronate (17.5 mg/week) treatment on quality of life in Japanese women with osteoporosis: a prospective observational study.
Topics: Aged; Aged, 80 and over; Asian People; Bone Density; Bone Density Conservation Agents; Comorbidity; | 2012 |